Is CBD Legal in Arizona? Arizona Cannabis, Hemp, and CBD Laws (2026)

Arizona permits qualifying hemp and has licensed medical and adult-use marijuana markets, but this does not make every CBD oil, gummy, drink, or supplement lawful. The product’s composition, intended use, and sales channel matter. In particular, Arizona health officials expressly warn against adding CBD to food or marketing it as a dietary supplement.

A medical card is not a general requirement for a lawful non-drug hemp product. Marijuana products follow the state’s cannabis rules, while prescription CBD medicine follows drug-approval and prescribing requirements. Our U.S. CBD legality guide explains how the federal rules interact with state requirements.

What Arizona’s Hemp Law Actually Covers

Arizona Revised Statutes Section 3-311 defines industrial hemp using a delta-9 THC concentration of no more than 0.3% on a dry-weight basis. Its definition of hemp products excludes products intended for ingestion, apart from food made from sterile hemp seed or hemp seed oil. Hemp seed oil and CBD extract are not interchangeable ingredients.

The Arizona Department of Agriculture administers the industrial hemp program. Production activities such as growing, harvesting, transporting crops, and processing involve agricultural licensing and compliance requirements. A production license does not authorize every possible finished product or therapeutic claim.

The department’s hemp FAQ distinguishes its agricultural oversight from other agencies’ food, manufacturing, and FDA requirements. Businesses should resolve those additional requirements for the exact product before manufacturing or selling it. A federal hemp classification alone is insufficient.

CBD Foods and Supplements: Arizona’s 2026 Warning

In a February 17, 2026 letter to county health departments, ADHS states that CBD must not be added to food or beverages and that marketing CBD as a dietary supplement is illegal. It directs county regulators to address violations in permitted retail food establishments.

The letter also addresses handling of sealed products and other dietary ingredients. Those provisions should not be read as approval to label CBD as a supplement: its CBD-specific prohibition remains explicit. A café cannot treat CBD as an ordinary approved ingredient simply because a supplier offers it in bulk.

The FDA’s federal requirements apply separately. CBD is excluded from dietary supplements, and introducing foods with added CBD into interstate commerce is generally prohibited. Cosmetics must meet applicable safety and labeling rules, and disease-treatment claims can turn a product into an unapproved drug.

Accordingly, a shelf stocked with CBD gummies does not prove that those products comply with Arizona or federal food law. Check the product category, ingredients, and regulator’s requirements rather than assuming that all non-intoxicating products share one permission.

Marijuana-Derived CBD and Licensed Dispensaries

CBD-containing products regulated as marijuana belong in Arizona’s licensed cannabis system. The Department of Health Services oversees that system. Adult-use purchases are for people 21 and older; registered medical patients follow the medical program’s eligibility and card requirements.

Under Section 36-2852, adults 21 and older may possess up to one ounce of marijuana, with no more than five grams of that amount in concentrate form. A CBD-rich marijuana extract is not exempt merely because it contains more CBD than THC.

The medical law defines a patient’s allowable amount as 2.5 ounces of usable marijuana. Dispensing rules and purchase tracking also apply; a possession limit should not be confused with permission to buy that amount repeatedly without regard to program restrictions. Minors require the medical program’s additional safeguards rather than ordinary adult-use access.

Delta-8 and Other Converted Intoxicating Cannabinoids

The Arizona Attorney General’s March 11, 2024 opinion concludes that unlicensed businesses may not sell delta-8 and other hemp-synthesized intoxicants. The opinion addresses intoxicating substances chemically converted from CBD or other cannabinoids, including delta-10, and explains why the state hemp statute does not legalize those products outside the licensed cannabis system.

The opinion is not approval for every converted product to be manufactured or stocked by a dispensary. Cannabis licensing and product rules must also be satisfied. A convenience-store product does not become lawful because its packaging says it was made from federally compliant hemp.

Non-intoxicating CBD and a chemically converted intoxicant raise different issues, but “non-intoxicating” is not an exemption from food law. For related terminology, see our HHC explainer.

Medical Certification and Prescription CBD

Arizona’s medical program uses a physician’s written certification and patient registration. The statutory definition of written certification requires an assessment within a physician-patient relationship and identification of the qualifying condition. Registration is distinct from simply buying a retail product marketed for wellness.

The federal rule effective April 28, 2026 places covered FDA-approved marijuana medicines and marijuana subject to state medical marijuana licensing in Schedule III. It establishes federal registration procedures and retains other controls. It does not turn every Arizona dispensary product into an FDA-approved medicine or remove the state’s patient-registration process.

Epidiolex is an FDA-approved cannabidiol medicine for specific seizure disorders and requires a prescription. Its approval does not apply to unrelated CBD oils or gummies. The FDA distinguishes approved drugs from other marketed CBD products.

Federal Hemp Changes in November and December 2026

Section 781 of Public Law 119-37 changes the federal hemp definition. The September 2026 extension in Section 2019 delays most amendments to December 11, 2026. November 12 remains the start for exclusions covering intermediate and final products containing cannabinoids the cannabis plant cannot naturally produce.

The December provisions include a total-THC definition that counts THCA and exclusions for naturally producible cannabinoids synthesized or manufactured outside the plant. Finished products above 0.4 mg per container of combined total THC and specified similarly acting cannabinoids are also excluded. The threshold measures the container, not one serving, and is not a cap on CBD itself.

Some full-spectrum CBD formulations can therefore lose their federal hemp status even when marketed as non-intoxicating. Arizona’s existing restrictions continue during the extension. The federal timetable does not create a temporary permission to sell CBD food or unlicensed intoxicating products.

Checking a CBD Product Before Buying

For a marijuana product, verify the seller’s ADHS license and follow the relevant adult-use or medical rules. For other CBD products, identify the legal product category and check applicable requirements with the regulator. Online availability or a company’s shipping policy is not a legal determination.

Ask for a recent certificate of analysis matching the product’s batch. Examine cannabinoid quantities and reporting limits, and consider the contents of the entire container. Full-spectrum, broad-spectrum, and isolate are descriptions of intended formulations, not government approvals. A laboratory report does not authorize a prohibited use or medical claim.

The supplier listings below are a starting point for product research. Check the exact formulation and current Arizona requirements before ordering; a brand listing does not establish that every item it offers may lawfully be sold into the state.